Provided by Tiger Trade Technology Pte. Ltd.

SHANDONG XINHUA

5.850
-0.180-2.99%
Volume:670.00K
Turnover:3.91M
Market Cap:4.08B
PE:13.93
High:6.060
Open:5.900
Low:5.805
Close:6.030
52wk High:7.748
52wk Low:5.029
Shares:697.00M
HK Float Shares:195.00M
Volume Ratio:1.43
T/O Rate:0.34%
Dividend:0.18
Dividend Rate:2.99%
EPS(LYR):0.420
ROE:4.99%
ROA:2.35%
PB:0.65
PE(LYR):13.93
PS:0.40

Loading ...

AH Share Premium and Deviation Data for June 9th

Stock News
·
Jun 09

AH Share Premium and Deviation Data for June 8th

Stock News
·
Jun 08

AH Premium and Deviation Rankings for June 4th

Stock News
·
Jun 04

Key Corporate Updates from Hong Kong-Listed Firms: Drug Approvals, A-Share Plans, and May Sales Figures

Stock News
·
Jun 02

Xinhua Pharmaceutical obtains Chinese approval for Sevelamer Carbonate suspension

Bulletin Express
·
Jun 01

Shandong Xinhua Pharmaceutical Receives Drug Registration Certificate for Sevelamer Carbonate Dry Suspension

Stock News
·
Jun 01

AH Share Premium and Deviation Rankings as of May 29 Close

Stock News
·
May 29

AH Premium and Deviation Rankings as of May 27th

Stock News
·
May 27

Shandong Xinhua: Shareholders Asked to Confirm Attendance for 2025 AGM on 26 June 2026

Bulletin Express
·
May 26

Shandong Xinhua Pharmaceutical Unveils AGM Agenda, Share Capital Update and Auditor Re-appointment

Bulletin Express
·
May 26

AH Premium and Deviation Rankings as of May 25th

Stock News
·
May 25

Xinhua Pharma's Anxiety Drug Passes Chinese Regulator's Quality Consistency Evaluation; Secures Approval

MT Newswires Live
·
May 18

SHANDONG XINHUA Announces Successful Generic Drug Consistency Evaluation for Phenobarbital Tablets

Stock News
·
May 18

Xinhua Pharma Secures Registration Certificate for Respiratory Oral Solution in China

MT Newswires Live
·
May 11

Xinhua Pharmaceutical obtains NMPA approval for Ambroxol-Clenbuterol oral solution

Bulletin Express
·
May 11

SHANDONG XINHUA (00719) Secures Drug Registration Certificate for Ambroxol and Clenbuterol Oral Solution

Stock News
·
May 11

Shandong Xinhua Pharmaceutical Shares Surge Over 7% After Approval for Self-Developed Benserazide Hydrochloride API

Stock News
·
May 11

Xinhua Pharmaceutical Gets China Nod to Market Parkinson's Drug

MT Newswires Live
·
May 08

SHANDONG XINHUA Receives Approval Notice for Benserazide Hydrochloride API

Stock News
·
May 08

China Oil and Gas swaps assets with Shengli for RMB 1.75 billion stake boost

Reuters
·
Apr 30